These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38050716)
1. A Proof-of-Concept Study on the Theranostic Potential of Chen X; Tan F; Liang R; Liao J; Yang J; Lan T; Yang Y; Liu N; Li F Chemistry; 2024 Feb; 30(9):e202303298. PubMed ID: 38050716 [TBL] [Abstract][Full Text] [Related]
2. Biocompatible conjugated polymer nanoparticles labeled with Chen X; Liang R; Liu W; Ma H; Bai C; Xiong Y; Lan T; Liao J; Yang Y; Yang J; Li F; Liu N Bioorg Med Chem; 2023 Dec; 96():117517. PubMed ID: 37939492 [TBL] [Abstract][Full Text] [Related]
3. Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles. Yook S; Lu Y; Jeong JJ; Cai Z; Tong L; Alwarda R; Pignol JP; Winnik MA; Reilly RM Biomacromolecules; 2016 Apr; 17(4):1292-302. PubMed ID: 26974228 [TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro evaluation of Zhang J; Wang Z; Liu H; Cai L; Feng Y; Zhou L; Wei H; Xie Y; Chen Y Hell J Nucl Med; 2019; 22(2):103-110. PubMed ID: 31273351 [TBL] [Abstract][Full Text] [Related]
5. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts. Persson M; Rasmussen P; Madsen J; Ploug M; Kjaer A Nucl Med Biol; 2012 Oct; 39(7):962-9. PubMed ID: 22739362 [TBL] [Abstract][Full Text] [Related]
6. Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer. Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM J Nucl Med; 2016 Jun; 57(6):936-42. PubMed ID: 26848176 [TBL] [Abstract][Full Text] [Related]
13. The preclinical study of Molavipordanjani S; Mousavi T; Khorramimoghaddam A; Talebpour Amiri F; Abedi SM; Hosseinimehr SJ Ann Nucl Med; 2023 Jul; 37(7):400-409. PubMed ID: 37115407 [TBL] [Abstract][Full Text] [Related]
14. A radio-theranostic nanoparticle with high specific drug loading for cancer therapy and imaging. Satterlee AB; Yuan H; Huang L J Control Release; 2015 Nov; 217():170-82. PubMed ID: 26341695 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of Lys¹(α,γ-Folate)Lys³(¹⁷⁷Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer. Aranda-Lara L; Ferro-Flores G; Azorín-Vega E; Ramírez FM; Jiménez-Mancilla N; Ocampo-García B; Santos-Cuevas C; Isaac-Olivé K Appl Radiat Isot; 2016 Jan; 107():214-219. PubMed ID: 26545016 [TBL] [Abstract][Full Text] [Related]
16. Huang Y; Yang Z; Li F; Zhao H; Li C; Yu N; Hamilton DJ; Li Z J Med Chem; 2021 Mar; 64(5):2705-2713. PubMed ID: 33646782 [TBL] [Abstract][Full Text] [Related]
17. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results. Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272 [TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy. Jiang L; Miao Z; Kimura RH; Liu H; Cochran JR; Culter CS; Bao A; Li P; Cheng Z Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):613-22. PubMed ID: 21153409 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [ Grzmil M; Qin Y; Schleuniger C; Frank S; Imobersteg S; Blanc A; Spillmann M; Berger P; Schibli R; Behe M Theranostics; 2020; 10(24):10861-10873. PubMed ID: 33042258 [No Abstract] [Full Text] [Related]